Home » In The News » Lysosomal storage disorder biotech Gain Therapeutics prices IPO at $11 midpoint
Nasdaq
Mar 18 2021
https://www.nasdaq.com/articles/lysosomal-storage-disorder-biotech-gain-therapeutics-prices-ipo-at-%2411-midpoint-2021-03-18